Seoul, KS, United States of America

Choong-Hahn Kim

This inventor holds 1 USPTO granted patent. Top assignee: Hanmi Science Co., Ltd.. Active years: 2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Choong-Hahn Kim. Retrieved from https://idiyas.com/inventor/choong-hahn-kim

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2013

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Choong-Hahn Kim

Introduction

Choong-Hahn Kim is a notable inventor based in Seoul, KS (US). He has made significant contributions to the field of pharmaceuticals, particularly in the preparation of Montelukast acid, a compound used in treating asthma and allergies.

Latest Patents

One of his key patents is titled "Method for preparation of Montelukast acid in ionic liquid medium." This invention relates to a method for preparing Montelukast acid or its sodium salt by reacting a thiol compound with a Montelukast intermediate in the presence of a base in a medium comprising an ionic liquid compound. The method allows for the easy preparation of highly pure Montelukast acid or its sodium salt, which is beneficial as a raw material in the preparation of Montelukast, a leukotriene antagonist. Choong-Hahn Kim holds 1 patent.

Career Highlights

Choong-Hahn Kim is associated with Hanmi Science Co., Ltd., where he continues to innovate and contribute to the pharmaceutical industry. His work has been instrumental in advancing methods that enhance the efficiency and purity of pharmaceutical compounds.

Collaborations

He has collaborated with notable coworkers, including Chul-Hyun Park and Eun-Ju Park, who share his commitment to innovation in the field.

Conclusion

Choong-Hahn Kim's contributions to the preparation of Montelukast acid exemplify the impact of innovative thinking in pharmaceuticals. His work not only advances scientific knowledge but also improves therapeutic options for patients.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…